FOXO3 and breast cancer: Abid et al. (2005) show that FOXO3 overexpression inhibited vascular smooth muscle cell proliferation and neointimal hyperplasia. Another study indicates that overexpression of FOXO3 results in suppression of growth and survival of breast cancer cells (Zou et al., 2008).